Establishment of antihuman IFN-alpha8-specific monoclonal antibodies and their application in the enzyme-linked immunosorbent assay (ELISA)

J Interferon Cytokine Res. 2008 Jun;28(6):359-66. doi: 10.1089/jir.2007.0121.

Abstract

In the present study, we describe the generation of a series of anti-interferon-alpha8 (IFN-alpha8)-specific monoclonal antibodies (mAbs), their characterization, and the establishment of a sandwich enzyme-linked immunosorbent assay (ELISA) system for human IFN-alpha8. The sandwich ELISA system is highly sensitive to human natural IFN-alpha8 (nIFN-alpha8), with a minimum detection limit of 50 pg/mL, which did not cross-react with the other IFN preparations and several cytokines tested. Using this ELISA system, pharmacokinetic properties of an IFN-alpha preparation administered in mice were examined. We found that IFN-alpha8 has higher vascular permeability and stability than IFN-alpha2 in the circulation. These results suggest that this ELISA would be very useful for determination of IFN-alpha8 protein concentrations in various experimental samples and also of pharmacokinetic properties of IFN-alpha preparations in human.

MeSH terms

  • Animals
  • Antibodies, Monoclonal* / immunology
  • Antibodies, Monoclonal* / isolation & purification
  • Antibodies, Monoclonal* / pharmacokinetics
  • Capillary Permeability
  • Cross Reactions
  • Enzyme-Linked Immunosorbent Assay*
  • Epitopes
  • Female
  • Humans
  • Hybridomas
  • Interferon-alpha
  • Interferons / immunology*
  • Interferons / pharmacokinetics
  • Mice
  • Mice, Inbred BALB C
  • Rats
  • Rats, Inbred BN
  • Sensitivity and Specificity

Substances

  • Antibodies, Monoclonal
  • Epitopes
  • IFNA8 protein, human
  • Interferon-alpha
  • Interferons